iShares Russell 2000 ETF vs UnitedHealth Group Inc — how do they compare? iShares Russell 2000 ETF trades at $278.93 (market cap $77.70B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 4.3× iShares Russell 2000 ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while iShares Russell 2000 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Russell 2000 ETF for 83 Days and UnitedHealth Group Inc for 97 Days on average.
| IWM | UNH | |
|---|---|---|
Market Cap | $77.70B | $332.96B |
Volume | 35,598,983 | 7,273,749 |
52-Week High | $305.06 | $436.35 |
52-Week Low | $229.13 | $259.02 |
Typical Hold Time | 83 Days | 97 Days |
Sector | — | Health |
Enterprise Value | — | $374.82B |
Dividend Yield | — | 2.5% |
Signals from Pluang's Aura AI — not financial advice
IWM trades at $277.63, showing minimal daily movement with a slight decline of 0.03%. Technical indicators signal a bearish trend with moving averages and ADX pointing downward, while oscillators remain neutral. The ETF faces headwinds from Federal Reserve rate hike concerns and underperformance relative to large-cap indices. Recent institutional selling and negative media coverage highlight ongoing challenges for small-cap exposure.
The outlook remains cautious as small-caps face pressure from tightening financial conditions and energy price volatility. While offering diversification from tech-heavy indices, IWM's inclusion of unprofitable companies and decade-long underperformance versus the S&P 500 present significant hurdles for near-term outperformance.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →